Cargando…
Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics
Globally, cancer is the second (to cardiovascular diseases) leading cause of death. Regardless of various efforts (i.e., finance, research, and workforce) to advance novel cancer theranostics (diagnosis and therapy), there have been few successful attempts towards ongoing clinical treatment options...
Autores principales: | Mkhatshwa, Marcus, Moremi, Joshua Mamolatelo, Makgopa, Katlego, Manicum, Amanda-Lee Ezra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235741/ https://www.ncbi.nlm.nih.gov/pubmed/34207182 http://dx.doi.org/10.3390/ijms22126546 |
Ejemplares similares
-
Anticancer Activities of Re(I) Tricarbonyl and Its
Imidazole-Based Ligands: Insight from a Theoretical Approach
por: Matlou, Mabu L., et al.
Publicado: (2023) -
Modeling of Re(I) tricarbonyl complexes against SARS-CoV-2 receptor via DFT, in-silico molecular docking, and QSAR
por: Eno, Ededet A., et al.
Publicado: (2022) -
Microporous Polymelamine Framework Functionalized with Re(I) Tricarbonyl Complexes for CO(2) Absorption and Reduction
por: Zappia, Stefania, et al.
Publicado: (2022) -
Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles
por: Press, Adrian T., et al.
Publicado: (2014) -
Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
por: Shigdar, Sarah, et al.
Publicado: (2013)